[ET Net News Agency, 16 September 2024] REMEGEN (09995) fell 20.2% to HK$10.3, dipping
below the 20-D SMA of HK$12.503.
It hits an intra-day low of HK$10.3, hitting a historical low, and an intra-day high of
HK$12.9. The total shares traded was 815,000, with a value of HK$9.22m. The active
buy/sell ratio is 30:70, with net selling turnover of HK$3.46m. HSBC SEC BRO (ASIA)
accounts for greatest net responsive buying turnover of HK$912,814, with volume weighted
average price of HK$11.966. MERRILL LYNCH FE accounts for greatest net responsive selling
turnover of HK$335,153, with volume weighted average price of HK$11.07.

Basic Information
=================

-----------------------------------
Nominal 10.300 % Chg -20.16%
High 12.900 Low 10.300
Shares Tr 815,000 Turnover 9.22m
10-D SMA 12.200 %H.V 59.367
20-D SMA 12.503 VWAP 11.311
50-D SMA 13.855 RSI14 29.312
-----------------------------------
Status: Dipping below the 20-D SMA, hitting a historical low, active buy/sell ratio is
30:70, with net selling turnover of HK$3.46m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 10.30 -20.16
IMMUNEONCO-B (01541) 7.12 +44.13
EVEREST MED-B (01952) 21.65 -7.87
KEYMED BIO-B (02162) 39.10 -1.64
WUXI XDC (02268) 20.30 +1.00
ASCENTAGE-B (06855) 32.30 -3.44
SKB BIO-B (06990) 179.50 -1.86
ZAI LAB (09688) 16.00 -0.12
AKESO (09926) 65.30 +5.92
INNOCARE (09969) 5.59 -3.12
---------------------------------------------
(ed)